AIM ImmunoTech (AIM) Capital Expenditures (QoQ) (2010 - 2021)
AIM ImmunoTech (AIM) Capital Expenditures (QoQ) (2010 - 2021) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | AIM ImmunoTech | 4.43 Mn | -5.53 Mn | 21,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -12.50% |
| Dec 31, 2020 | 125.00% |
| Sep 30, 2020 | 100.00% |
| Jun 30, 2020 | -71.43% |
| Sep 30, 2019 | -89.80% |
| Jun 30, 2019 | 250.00% |
| Mar 31, 2019 | 366.67% |
| Dec 31, 2015 | 200.00% |
| Sep 30, 2015 | -107.25% |
| Jun 30, 2015 | 310.64% |
| Mar 31, 2015 | -60.17% |
| Dec 31, 2014 | -1.67% |
| Sep 30, 2014 | -40.30% |
| Jun 30, 2014 | 209.23% |
| Mar 31, 2014 | -56.95% |
| Dec 31, 2013 | -29.11% |
| Sep 30, 2013 | -26.55% |
| Jun 30, 2013 | 18.85% |
| Mar 31, 2013 | -95.76% |
| Dec 31, 2012 | 279.25% |